| Item 1. |
Security and Issuer |
This Statement relates to the common stock, par value $0.10 per share, of ImmuCell Corporation, a Delaware corporation (the “Company”). The
Company’s principal executive offices are located at 56 Evergreen Drive, Portland, Maine 04103.
| Item 2. |
Identity and Background. |
| |
(a) |
Name. The name of the Reporting Person is Ejnar A. Knudsen III. |
| |
(b) |
Business Address. The business address of the Reporting Person is 212 West Superior, Suite 500, Chicago,
IL 60654. |
| |
(c) |
Occupation and Employment. The Reporting Person is the founder and chief executive officer of AGR
Partners. |
| |
(d) |
Criminal Proceedings. During the last five years, the Reporting Person has not been convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors). |
| |
(e) |
Civil Proceedings. During the last five years, the Reporting Person has not been a party to a civil
proceeding of a judicial or administrative body of competent jurisdiction as a result of which the Reporting Person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject
to, federal or state securities laws or finding any violation with respect to such laws. |
| |
(f) |
Citizenship. The Reporting Person is a citizen of the United States. |
| Item 3. |
Source and Amount of Funds or Other Consideration |
On August 21, 2024, the Reporting Person acquired beneficial ownership of 300,000 shares of Company’s common stock which, when combined with earlier
purchases, resulted in the Reporting Person holding more than 5.0% of the Company’s outstanding common stock. The purchases were made using general investment funds.
| Item 4. |
Purpose of Transaction |
All shares held by the Reporting Person are held by the Reporting Person for investment purposes.
The Reporting Person currently has no plans or proposals that relate to, or would result in, any of the matters described in subsections (a) through
(j) of Item 4 of the instructions to Schedule 13D.
| Item 5. |
Interest in Securities of the Issuer |
As of the date hereof, the Reporting Person is the beneficial owner of 463,619 shares of common stock representing approximately 5.9% of the approximately
7,833,080 shares outstanding, as disclosed in the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 13, 2024.
The Reporting Person’s ownership consists of 386,425 owned by the Reporting Person directly, 9,539 shares owned by the Reporting Person’s four minor
children, 37,383 shares held by the 2007 Knudsen Family Trust, of which the Reporting Person is trustee, 19,684 held by Knudsen Family Holdings, a limited liability company which the Reporting Person controls, 6,088 shares attributable to the
Reporting Person’s Simplified Employee Pension account and 4,500 shares attributable to the individual retirement account of the Reporting Person’s spouse.